SuperworthPTC Therapeutics shares outstanding PTCT
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 92M
- On a year earlier
- +17.7%
- more shares
PTC Therapeutics had 92M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 17.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 82.2M | +6% |
| FY2024 | 77.2M | +2% |
| FY2023 | 75.5M | +4% |
| FY2022 | 72.7M | +3% |
| FY2021 | 70.7M | +3% |
| FY2020 | 68.9M | +11% |
| FY2019 | 62M | +23% |
| FY2018 | 50.3M | +22% |
| FY2017 | 41.4M | +21% |
| FY2016 | 34.2M | +1% |
| FY2015 | 33.9M | −17% |
| FY2014 | 40.8M | +69% |
| FY2013 | 24.2M | +86471% |
| FY2012 | 28K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 92M | +18% | |
| Q1 FY26 | 82.5M | −4% | |
| Q4 FY25 | 82.2M | +6% | |
| Q3 FY25 | 87.1M | +13% | |
| Q2 FY25 | 78.2M | +2% | |
| Q1 FY25 | 86.4M | +13% | |
| Q4 FY24 | 77.2M | +2% | |
| Q3 FY24 | 76.9M | +2% | |
| Q2 FY24 | 76.7M | +3% | |
| Q1 FY24 | 76.5M | +4% | |
| Q4 FY23 | 75.5M | +4% | |
| Q3 FY23 | 75.4M | +5% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on PTC Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.